CA2871265C - Therapeutic use of chardonnay seed products - Google Patents

Therapeutic use of chardonnay seed products Download PDF

Info

Publication number
CA2871265C
CA2871265C CA2871265A CA2871265A CA2871265C CA 2871265 C CA2871265 C CA 2871265C CA 2871265 A CA2871265 A CA 2871265A CA 2871265 A CA2871265 A CA 2871265A CA 2871265 C CA2871265 C CA 2871265C
Authority
CA
Canada
Prior art keywords
chardonnay
chardonnay seed
seed flour
mammal
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2871265A
Other languages
English (en)
French (fr)
Other versions
CA2871265A1 (en
Inventor
Torey James ARVIK
Rebecca Susan LIPSON
Wallace H. Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Agriculture USDA
Sonomaceuticals LLC
Original Assignee
US Department of Agriculture USDA
Sonomaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Agriculture USDA, Sonomaceuticals LLC filed Critical US Department of Agriculture USDA
Publication of CA2871265A1 publication Critical patent/CA2871265A1/en
Application granted granted Critical
Publication of CA2871265C publication Critical patent/CA2871265C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2871265A 2012-04-30 2013-04-29 Therapeutic use of chardonnay seed products Active CA2871265C (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261640622P 2012-04-30 2012-04-30
US61/640,622 2012-04-30
US201261691515P 2012-08-21 2012-08-21
US61/691,515 2012-08-21
US201361798992P 2013-03-15 2013-03-15
US61/798,992 2013-03-15
PCT/US2013/038696 WO2013165921A2 (en) 2012-04-30 2013-04-29 Therapeutic use of chardonnay seed products

Publications (2)

Publication Number Publication Date
CA2871265A1 CA2871265A1 (en) 2013-11-07
CA2871265C true CA2871265C (en) 2021-07-13

Family

ID=48430944

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2871265A Active CA2871265C (en) 2012-04-30 2013-04-29 Therapeutic use of chardonnay seed products

Country Status (14)

Country Link
US (4) US10105409B2 (h)
EP (1) EP2844266B1 (h)
JP (1) JP6562837B2 (h)
KR (1) KR102149348B1 (h)
CN (2) CN110433230A (h)
AU (1) AU2013256577B2 (h)
BR (1) BR112014026926B1 (h)
CA (1) CA2871265C (h)
EA (1) EA201491817A1 (h)
ES (1) ES2990038T3 (h)
IL (1) IL235349B (h)
IN (1) IN2014DN09085A (h)
NZ (1) NZ701607A (h)
WO (1) WO2013165921A2 (h)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013165921A2 (en) 2012-04-30 2013-11-07 Sonomaceuticals, Llc Therapeutic use of chardonnay seed products
CA2946558A1 (en) 2014-04-21 2015-10-29 Sonomaceuticals, Llc Therapeutic use of grape seed products for the treatment of joint pain and/or joint inflammation
CN106455637A (zh) 2014-05-30 2017-02-22 嘉康利公司 霞多丽葡萄籽提取物
US10709751B2 (en) 2014-05-30 2020-07-14 Shaklee Corporation Chardonnay grape seed extract
CA2971716A1 (en) 2014-12-20 2016-06-23 Sonomaceuticals, Llc Grape products for nonalcoholic fatty liver disease and other uses
EP4545082A3 (en) 2015-05-06 2025-07-02 SNIPR Technologies Limited Altering microbial populations & modifying microbiota
ITUB20154797A1 (it) * 2015-10-20 2016-01-20 Francesco Donati Insieme di polveri per l'estrazione di bevande, e metodo per la realizzazione di tale insieme
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
EP3554254B1 (en) * 2016-12-15 2025-05-07 Société des Produits Nestlé S.A. Compositions and methods that modulate bacteria in a companion animal
EP3630146A1 (en) * 2017-06-02 2020-04-08 Goodgut S.L. Grape skin for use in the treatment of dysbiosis
KR102037898B1 (ko) * 2017-12-26 2019-10-30 한양대학교 산학협력단 케피어 유래 유산균 및 포도씨 분말을 포함하는 지방간의 예방 또는 치료용 조성물
KR102037897B1 (ko) * 2017-12-26 2019-10-30 한양대학교 산학협력단 케피어 유래 유산균 및 포도씨 분말을 포함하는 비만의 예방 또는 치료용 조성물
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
KR102217834B1 (ko) * 2018-11-13 2021-02-19 한양대학교 산학협력단 케피어 유래 유산균의 사균체 및 포도씨 분말을 함유하는 비만의 예방 또는 치료용 조성물
JP7279943B2 (ja) * 2020-07-03 2023-05-23 株式会社エーゼット ブドウ種子抽出物を含む更年期障害改善剤
RU2747660C1 (ru) * 2020-07-06 2021-05-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный технологический университет" (ФГБОУ ВО "КубГТУ") Способ персонификации питания с учетом генетически детерминированных факторов
EP4228419A4 (en) * 2020-10-16 2024-10-23 Sonomaceuticals, LLC FOOD COMPOSITIONS COMPRISING AGRICULTURAL MARC, AND ASSOCIATED PRODUCTION METHODS
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1951200A (en) 2000-02-28 2001-08-30 Vo Hanh Nhu Thi Seedless chardonnay
US20020192314A1 (en) * 2001-03-06 2002-12-19 Cho Suk H. Dietary supplement compositions
KR100448447B1 (ko) * 2002-12-17 2004-09-13 주식회사 엔바이오테크놀러지 알파 글루코시다제 저해활성을 갖는 포도씨 추출물을함유하는 조성물, 제조방법 및 이의 용도
WO2005048719A1 (en) 2003-11-17 2005-06-02 Wisconsin Alumni Research Foundation Polyphenol-containing stem and vine extracts and methods of use
US20060172012A1 (en) 2005-01-28 2006-08-03 Finley John W Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
CN101277616A (zh) * 2005-09-28 2008-10-01 美露香株式会社 γ-氨基丁酸含量提高的果实的制造方法
CN100571537C (zh) * 2006-11-07 2009-12-23 西北农林科技大学 一种葡萄籽超微粉胶囊的生产方法
US20090082738A1 (en) 2007-09-24 2009-03-26 Vad Vijay B Natural Anti-Inflammatory Agents for Reducing Pain
CN102612564B (zh) 2009-04-10 2015-08-26 齐海燕 新的抗衰老试剂及其鉴别方法
US20110217417A1 (en) * 2009-05-04 2011-09-08 Daniel Perlman Phenolic antioxidant-supplemented infusion beverage
DE202009013228U1 (de) * 2009-09-30 2011-02-10 Tavarlin Ag Glutenfreie Nahrungsmittel
WO2013165921A2 (en) * 2012-04-30 2013-11-07 Sonomaceuticals, Llc Therapeutic use of chardonnay seed products
CA2946558A1 (en) 2014-04-21 2015-10-29 Sonomaceuticals, Llc Therapeutic use of grape seed products for the treatment of joint pain and/or joint inflammation

Also Published As

Publication number Publication date
EP2844266B1 (en) 2024-09-11
WO2013165921A3 (en) 2014-01-03
CN110433230A (zh) 2019-11-12
EA201491817A1 (ru) 2015-04-30
KR20150018784A (ko) 2015-02-24
IL235349A0 (en) 2014-12-31
US20150132419A1 (en) 2015-05-14
EP2844266C0 (en) 2024-09-11
BR112014026926B1 (pt) 2021-03-09
BR112014026926A2 (pt) 2017-06-27
US20240024404A1 (en) 2024-01-25
US11723943B2 (en) 2023-08-15
IL235349B (en) 2020-11-30
CN104519895A (zh) 2015-04-15
JP6562837B2 (ja) 2019-08-21
EP2844266A2 (en) 2015-03-11
KR102149348B1 (ko) 2020-08-31
US20210236579A1 (en) 2021-08-05
US10105409B2 (en) 2018-10-23
WO2013165921A2 (en) 2013-11-07
JP2015523321A (ja) 2015-08-13
CA2871265A1 (en) 2013-11-07
CN104519895B (zh) 2019-06-11
AU2013256577B2 (en) 2018-03-01
AU2013256577A1 (en) 2014-11-20
IN2014DN09085A (h) 2015-05-22
US20190269748A1 (en) 2019-09-05
NZ701607A (en) 2017-04-28
ES2990038T3 (es) 2024-11-28
US10772924B2 (en) 2020-09-15

Similar Documents

Publication Publication Date Title
US11723943B2 (en) Therapeutic use of chardonnay seed products
JP4562352B2 (ja) コレステロール低下用改良食用組成物類
JP2021052756A (ja) 苦みの少ないチコリ生成物
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) et al. Re‐evaluation of guar gum (E 412) as a food additive
Thakuria et al. Sriram: An in vitro study of the prebiotic properties of Xylooligosaccharide (XOS) and organoleptic evaluation of XOS added Prawn patia and Black rice kheer
EP3197297B1 (en) Prebiotic inulin based preparation
JPWO2004084919A1 (ja) 血中低分子量含窒素化合物の濃度を低減させる病態改善用食品
Annapure et al. Prebiotic and Synbiotic Foods
WO2018056284A1 (ja) 腸内菌叢改善用組成物
JP2020127392A (ja) イヌリンを含む整腸剤
JP7601332B2 (ja) 便秘解消組成物
JP2020129986A (ja) 経口組成物
JP2011246414A (ja) 筋肉組織における脂質代謝促進剤
Baltacıoğlu Production of chips and crisp from jerusalem artichoke
Skiba Determinants of the Quality of Food Preparations
JP2022130294A (ja) 腸内環境改善剤及び組成物
JP2020158440A (ja) 二次胆汁酸の生成抑制剤
Sterner Six foods to help you lose weight and feel better
JP2018100263A (ja) 肌質改善組成物
SANDHYA EFFECT OF INULIN ON THE QUALITY OF FLAT BREAD (ROTI) AND BISCUITS MADE OF SORGHUM (Sorghum bicolour (L.) moench)
JP2016028600A (ja) 筋肉組織における脂質代謝促進剤

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180425